Click for best price
Respiratory Syncytial Virus Vaccines Market Size, Share 2023
This report aims to provide a comprehensive presentation of the global market for Respiratory Syncytial Virus Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Respiratory Syncytial Virus Vaccines. This report contains market size and forecasts of Respiratory Syncytial Virus Vaccines in global, including the following market information:
Global Respiratory Syncytial Virus Vaccines Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Respiratory Syncytial Virus Vaccines market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Palivizumab Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Respiratory Syncytial Virus Vaccines include Pfizer Inc.Pfizer Inc., Sanofi, Merck Sharp & Dohme, GlaxoSmithKline, SOBI, Johnson & Johnson, Bavarian Nordic, Novavax and AstraZeneca, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Respiratory Syncytial Virus Vaccines companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Respiratory Syncytial Virus Vaccines Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Respiratory Syncytial Virus Vaccines Market Segment Percentages, by Type, 2022 (%)
Palivizumab
RSVpreF PF06928316
RSVPreF3 OA (GSK3844766A)
mRNA-1345
Janssen RSV Vaccine
ResVax
Nirsevimab (MEDI8897)
MVA-BN RSV
Global Respiratory Syncytial Virus Vaccines Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Respiratory Syncytial Virus Vaccines Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinic
Research Institute
Global Respiratory Syncytial Virus Vaccines Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Respiratory Syncytial Virus Vaccines Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Respiratory Syncytial Virus Vaccines revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Respiratory Syncytial Virus Vaccines revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer Inc.Pfizer Inc.
Sanofi
Merck Sharp & Dohme
GlaxoSmithKline
SOBI
Johnson & Johnson
Bavarian Nordic
Novavax
AstraZeneca
Moderna
Codagenix
Intravacc
Alphavax
Outline of Major Chapters:
Chapter 1: Introduces the definition of Respiratory Syncytial Virus Vaccines, market overview.
Chapter 2: Global Respiratory Syncytial Virus Vaccines market size in revenue.
Chapter 3: Detailed analysis of Respiratory Syncytial Virus Vaccines company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Respiratory Syncytial Virus Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Respiratory Syncytial Virus Vaccines Market, Global Outlook and Forecast 2023-2029 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
62 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Respiratory Syncytial Virus Vaccines Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Respiratory Syncytial Virus Vaccines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Respiratory Syncytial Virus Vaccines Overall Market Size
2.1 Global Respiratory Syncytial Virus Vaccines Market Size: 2022 VS 2029
2.2 Global Respiratory Syncytial Virus Vaccines Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Respiratory Syncytial Virus Vaccines Players in Global Market
3.2 Top Global Respiratory Syncytial Virus Vaccines Companies Ranked by Revenue
3.3 Global Respiratory Syncytial Virus Vaccines Revenue by Companies
3.4 Top 3 and Top 5 Respiratory Syncytial Virus Vaccines Companies in Global Market, by Revenue in 2022
3.5 Global Companies Respiratory Syncytial Virus Vaccines Product Type
3.6 Tier 1, Tier 2 and Tier 3 Respiratory Syncytial Virus Vaccines Players in Global Market
3.6.1 List of Global Tier 1 Respiratory Syncytial Virus Vaccines Companies
3.6.2 List of Global Tier 2 and Tier 3 Respiratory Syncytial Virus Vaccines Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Respiratory Syncytial Virus Vaccines Market Size Markets, 2022 & 2029
4.1.2 Palivizumab
4.1.3 RSVpreF PF06928316
4.1.4 RSVPreF3 OA (GSK3844766A)
4.1.5 mRNA-1345
4.1.6 Janssen RSV Vaccine
4.1.7 ResVax
4.1.8 Nirsevimab (MEDI8897)
4.1.9 MVA-BN RSV
4.2 By Type - Global Respiratory Syncytial Virus Vaccines Revenue & Forecasts
4.2.1 By Type - Global Respiratory Syncytial Virus Vaccines Revenue, 2018-2023
4.2.2 By Type - Global Respiratory Syncytial Virus Vaccines Revenue, 2024-2029
4.2.3 By Type - Global Respiratory Syncytial Virus Vaccines Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Respiratory Syncytial Virus Vaccines Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Research Institute
5.2 By Application - Global Respiratory Syncytial Virus Vaccines Revenue & Forecasts
5.2.1 By Application - Global Respiratory Syncytial Virus Vaccines Revenue, 2018-2023
5.2.2 By Application - Global Respiratory Syncytial Virus Vaccines Revenue, 2024-2029
5.2.3 By Application - Global Respiratory Syncytial Virus Vaccines Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Respiratory Syncytial Virus Vaccines Market Size, 2022 & 2029
6.2 By Region - Global Respiratory Syncytial Virus Vaccines Revenue & Forecasts
6.2.1 By Region - Global Respiratory Syncytial Virus Vaccines Revenue, 2018-2023
6.2.2 By Region - Global Respiratory Syncytial Virus Vaccines Revenue, 2024-2029
6.2.3 By Region - Global Respiratory Syncytial Virus Vaccines Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Respiratory Syncytial Virus Vaccines Revenue, 2018-2029
6.3.2 US Respiratory Syncytial Virus Vaccines Market Size, 2018-2029
6.3.3 Canada Respiratory Syncytial Virus Vaccines Market Size, 2018-2029
6.3.4 Mexico Respiratory Syncytial Virus Vaccines Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Respiratory Syncytial Virus Vaccines Revenue, 2018-2029
6.4.2 Germany Respiratory Syncytial Virus Vaccines Market Size, 2018-2029
6.4.3 France Respiratory Syncytial Virus Vaccines Market Size, 2018-2029
6.4.4 U.K. Respiratory Syncytial Virus Vaccines Market Size, 2018-2029
6.4.5 Italy Respiratory Syncytial Virus Vaccines Market Size, 2018-2029
6.4.6 Russia Respiratory Syncytial Virus Vaccines Market Size, 2018-2029
6.4.7 Nordic Countries Respiratory Syncytial Virus Vaccines Market Size, 2018-2029
6.4.8 Benelux Respiratory Syncytial Virus Vaccines Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Respiratory Syncytial Virus Vaccines Revenue, 2018-2029
6.5.2 China Respiratory Syncytial Virus Vaccines Market Size, 2018-2029
6.5.3 Japan Respiratory Syncytial Virus Vaccines Market Size, 2018-2029
6.5.4 South Korea Respiratory Syncytial Virus Vaccines Market Size, 2018-2029
6.5.5 Southeast Asia Respiratory Syncytial Virus Vaccines Market Size, 2018-2029
6.5.6 India Respiratory Syncytial Virus Vaccines Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Respiratory Syncytial Virus Vaccines Revenue, 2018-2029
6.6.2 Brazil Respiratory Syncytial Virus Vaccines Market Size, 2018-2029
6.6.3 Argentina Respiratory Syncytial Virus Vaccines Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Respiratory Syncytial Virus Vaccines Revenue, 2018-2029
6.7.2 Turkey Respiratory Syncytial Virus Vaccines Market Size, 2018-2029
6.7.3 Israel Respiratory Syncytial Virus Vaccines Market Size, 2018-2029
6.7.4 Saudi Arabia Respiratory Syncytial Virus Vaccines Market Size, 2018-2029
6.7.5 UAE Respiratory Syncytial Virus Vaccines Market Size, 2018-2029
7 Respiratory Syncytial Virus Vaccines Companies Profiles
7.1 Pfizer Inc.Pfizer Inc.
7.1.1 Pfizer Inc.Pfizer Inc. Company Summary
7.1.2 Pfizer Inc.Pfizer Inc. Business Overview
7.1.3 Pfizer Inc.Pfizer Inc. Respiratory Syncytial Virus Vaccines Major Product Offerings
7.1.4 Pfizer Inc.Pfizer Inc. Respiratory Syncytial Virus Vaccines Revenue in Global Market (2018-2023)
7.1.5 Pfizer Inc.Pfizer Inc. Key News & Latest Developments
7.2 Sanofi
7.2.1 Sanofi Company Summary
7.2.2 Sanofi Business Overview
7.2.3 Sanofi Respiratory Syncytial Virus Vaccines Major Product Offerings
7.2.4 Sanofi Respiratory Syncytial Virus Vaccines Revenue in Global Market (2018-2023)
7.2.5 Sanofi Key News & Latest Developments
7.3 Merck Sharp & Dohme
7.3.1 Merck Sharp & Dohme Company Summary
7.3.2 Merck Sharp & Dohme Business Overview
7.3.3 Merck Sharp & Dohme Respiratory Syncytial Virus Vaccines Major Product Offerings
7.3.4 Merck Sharp & Dohme Respiratory Syncytial Virus Vaccines Revenue in Global Market (2018-2023)
7.3.5 Merck Sharp & Dohme Key News & Latest Developments
7.4 GlaxoSmithKline
7.4.1 GlaxoSmithKline Company Summary
7.4.2 GlaxoSmithKline Business Overview
7.4.3 GlaxoSmithKline Respiratory Syncytial Virus Vaccines Major Product Offerings
7.4.4 GlaxoSmithKline Respiratory Syncytial Virus Vaccines Revenue in Global Market (2018-2023)
7.4.5 GlaxoSmithKline Key News & Latest Developments
7.5 SOBI
7.5.1 SOBI Company Summary
7.5.2 SOBI Business Overview
7.5.3 SOBI Respiratory Syncytial Virus Vaccines Major Product Offerings
7.5.4 SOBI Respiratory Syncytial Virus Vaccines Revenue in Global Market (2018-2023)
7.5.5 SOBI Key News & Latest Developments
7.6 Johnson & Johnson
7.6.1 Johnson & Johnson Company Summary
7.6.2 Johnson & Johnson Business Overview
7.6.3 Johnson & Johnson Respiratory Syncytial Virus Vaccines Major Product Offerings
7.6.4 Johnson & Johnson Respiratory Syncytial Virus Vaccines Revenue in Global Market (2018-2023)
7.6.5 Johnson & Johnson Key News & Latest Developments
7.7 Bavarian Nordic
7.7.1 Bavarian Nordic Company Summary
7.7.2 Bavarian Nordic Business Overview
7.7.3 Bavarian Nordic Respiratory Syncytial Virus Vaccines Major Product Offerings
7.7.4 Bavarian Nordic Respiratory Syncytial Virus Vaccines Revenue in Global Market (2018-2023)
7.7.5 Bavarian Nordic Key News & Latest Developments
7.8 Novavax
7.8.1 Novavax Company Summary
7.8.2 Novavax Business Overview
7.8.3 Novavax Respiratory Syncytial Virus Vaccines Major Product Offerings
7.8.4 Novavax Respiratory Syncytial Virus Vaccines Revenue in Global Market (2018-2023)
7.8.5 Novavax Key News & Latest Developments
7.9 AstraZeneca
7.9.1 AstraZeneca Company Summary
7.9.2 AstraZeneca Business Overview
7.9.3 AstraZeneca Respiratory Syncytial Virus Vaccines Major Product Offerings
7.9.4 AstraZeneca Respiratory Syncytial Virus Vaccines Revenue in Global Market (2018-2023)
7.9.5 AstraZeneca Key News & Latest Developments
7.10 Moderna
7.10.1 Moderna Company Summary
7.10.2 Moderna Business Overview
7.10.3 Moderna Respiratory Syncytial Virus Vaccines Major Product Offerings
7.10.4 Moderna Respiratory Syncytial Virus Vaccines Revenue in Global Market (2018-2023)
7.10.5 Moderna Key News & Latest Developments
7.11 Codagenix
7.11.1 Codagenix Company Summary
7.11.2 Codagenix Business Overview
7.11.3 Codagenix Respiratory Syncytial Virus Vaccines Major Product Offerings
7.11.4 Codagenix Respiratory Syncytial Virus Vaccines Revenue in Global Market (2018-2023)
7.11.5 Codagenix Key News & Latest Developments
7.12 Intravacc
7.12.1 Intravacc Company Summary
7.12.2 Intravacc Business Overview
7.12.3 Intravacc Respiratory Syncytial Virus Vaccines Major Product Offerings
7.12.4 Intravacc Respiratory Syncytial Virus Vaccines Revenue in Global Market (2018-2023)
7.12.5 Intravacc Key News & Latest Developments
7.13 Alphavax
7.13.1 Alphavax Company Summary
7.13.2 Alphavax Business Overview
7.13.3 Alphavax Respiratory Syncytial Virus Vaccines Major Product Offerings
7.13.4 Alphavax Respiratory Syncytial Virus Vaccines Revenue in Global Market (2018-2023)
7.13.5 Alphavax Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Respiratory Syncytial Virus Vaccines Market Opportunities & Trends in Global Market
Table 2. Respiratory Syncytial Virus Vaccines Market Drivers in Global Market
Table 3. Respiratory Syncytial Virus Vaccines Market Restraints in Global Market
Table 4. Key Players of Respiratory Syncytial Virus Vaccines in Global Market
Table 5. Top Respiratory Syncytial Virus Vaccines Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Respiratory Syncytial Virus Vaccines Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Respiratory Syncytial Virus Vaccines Revenue Share by Companies, 2018-2023
Table 8. Global Companies Respiratory Syncytial Virus Vaccines Product Type
Table 9. List of Global Tier 1 Respiratory Syncytial Virus Vaccines Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Respiratory Syncytial Virus Vaccines Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Respiratory Syncytial Virus Vaccines Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Respiratory Syncytial Virus Vaccines Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Respiratory Syncytial Virus Vaccines Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Respiratory Syncytial Virus Vaccines Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Respiratory Syncytial Virus Vaccines Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Respiratory Syncytial Virus Vaccines Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Respiratory Syncytial Virus Vaccines Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Respiratory Syncytial Virus Vaccines Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Respiratory Syncytial Virus Vaccines Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Respiratory Syncytial Virus Vaccines Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Respiratory Syncytial Virus Vaccines Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Respiratory Syncytial Virus Vaccines Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Respiratory Syncytial Virus Vaccines Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Respiratory Syncytial Virus Vaccines Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Respiratory Syncytial Virus Vaccines Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Respiratory Syncytial Virus Vaccines Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Respiratory Syncytial Virus Vaccines Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Respiratory Syncytial Virus Vaccines Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Respiratory Syncytial Virus Vaccines Revenue, (US$, Mn), 2024-2029
Table 30. Pfizer Inc.Pfizer Inc. Company Summary
Table 31. Pfizer Inc.Pfizer Inc. Respiratory Syncytial Virus Vaccines Product Offerings
Table 32. Pfizer Inc.Pfizer Inc. Respiratory Syncytial Virus Vaccines Revenue (US$, Mn) & (2018-2023)
Table 33. Pfizer Inc.Pfizer Inc. Key News & Latest Developments
Table 34. Sanofi Company Summary
Table 35. Sanofi Respiratory Syncytial Virus Vaccines Product Offerings
Table 36. Sanofi Respiratory Syncytial Virus Vaccines Revenue (US$, Mn) & (2018-2023)
Table 37. Sanofi Key News & Latest Developments
Table 38. Merck Sharp & Dohme Company Summary
Table 39. Merck Sharp & Dohme Respiratory Syncytial Virus Vaccines Product Offerings
Table 40. Merck Sharp & Dohme Respiratory Syncytial Virus Vaccines Revenue (US$, Mn) & (2018-2023)
Table 41. Merck Sharp & Dohme Key News & Latest Developments
Table 42. GlaxoSmithKline Company Summary
Table 43. GlaxoSmithKline Respiratory Syncytial Virus Vaccines Product Offerings
Table 44. GlaxoSmithKline Respiratory Syncytial Virus Vaccines Revenue (US$, Mn) & (2018-2023)
Table 45. GlaxoSmithKline Key News & Latest Developments
Table 46. SOBI Company Summary
Table 47. SOBI Respiratory Syncytial Virus Vaccines Product Offerings
Table 48. SOBI Respiratory Syncytial Virus Vaccines Revenue (US$, Mn) & (2018-2023)
Table 49. SOBI Key News & Latest Developments
Table 50. Johnson & Johnson Company Summary
Table 51. Johnson & Johnson Respiratory Syncytial Virus Vaccines Product Offerings
Table 52. Johnson & Johnson Respiratory Syncytial Virus Vaccines Revenue (US$, Mn) & (2018-2023)
Table 53. Johnson & Johnson Key News & Latest Developments
Table 54. Bavarian Nordic Company Summary
Table 55. Bavarian Nordic Respiratory Syncytial Virus Vaccines Product Offerings
Table 56. Bavarian Nordic Respiratory Syncytial Virus Vaccines Revenue (US$, Mn) & (2018-2023)
Table 57. Bavarian Nordic Key News & Latest Developments
Table 58. Novavax Company Summary
Table 59. Novavax Respiratory Syncytial Virus Vaccines Product Offerings
Table 60. Novavax Respiratory Syncytial Virus Vaccines Revenue (US$, Mn) & (2018-2023)
Table 61. Novavax Key News & Latest Developments
Table 62. AstraZeneca Company Summary
Table 63. AstraZeneca Respiratory Syncytial Virus Vaccines Product Offerings
Table 64. AstraZeneca Respiratory Syncytial Virus Vaccines Revenue (US$, Mn) & (2018-2023)
Table 65. AstraZeneca Key News & Latest Developments
Table 66. Moderna Company Summary
Table 67. Moderna Respiratory Syncytial Virus Vaccines Product Offerings
Table 68. Moderna Respiratory Syncytial Virus Vaccines Revenue (US$, Mn) & (2018-2023)
Table 69. Moderna Key News & Latest Developments
Table 70. Codagenix Company Summary
Table 71. Codagenix Respiratory Syncytial Virus Vaccines Product Offerings
Table 72. Codagenix Respiratory Syncytial Virus Vaccines Revenue (US$, Mn) & (2018-2023)
Table 73. Codagenix Key News & Latest Developments
Table 74. Intravacc Company Summary
Table 75. Intravacc Respiratory Syncytial Virus Vaccines Product Offerings
Table 76. Intravacc Respiratory Syncytial Virus Vaccines Revenue (US$, Mn) & (2018-2023)
Table 77. Intravacc Key News & Latest Developments
Table 78. Alphavax Company Summary
Table 79. Alphavax Respiratory Syncytial Virus Vaccines Product Offerings
Table 80. Alphavax Respiratory Syncytial Virus Vaccines Revenue (US$, Mn) & (2018-2023)
Table 81. Alphavax Key News & Latest Developments
List of Figures
Figure 1. Respiratory Syncytial Virus Vaccines Segment by Type in 2022
Figure 2. Respiratory Syncytial Virus Vaccines Segment by Application in 2022
Figure 3. Global Respiratory Syncytial Virus Vaccines Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Respiratory Syncytial Virus Vaccines Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Respiratory Syncytial Virus Vaccines Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Respiratory Syncytial Virus Vaccines Revenue in 2022
Figure 8. By Type - Global Respiratory Syncytial Virus Vaccines Revenue Market Share, 2018-2029
Figure 9. By Application - Global Respiratory Syncytial Virus Vaccines Revenue Market Share, 2018-2029
Figure 10. By Type - Global Respiratory Syncytial Virus Vaccines Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Respiratory Syncytial Virus Vaccines Revenue Market Share, 2018-2029
Figure 12. By Application - Global Respiratory Syncytial Virus Vaccines Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Respiratory Syncytial Virus Vaccines Revenue Market Share, 2018-2029
Figure 14. By Region - Global Respiratory Syncytial Virus Vaccines Revenue Market Share, 2018-2029
Figure 15. By Country - North America Respiratory Syncytial Virus Vaccines Revenue Market Share, 2018-2029
Figure 16. US Respiratory Syncytial Virus Vaccines Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Respiratory Syncytial Virus Vaccines Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Respiratory Syncytial Virus Vaccines Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Respiratory Syncytial Virus Vaccines Revenue Market Share, 2018-2029
Figure 20. Germany Respiratory Syncytial Virus Vaccines Revenue, (US$, Mn), 2018-2029
Figure 21. France Respiratory Syncytial Virus Vaccines Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Respiratory Syncytial Virus Vaccines Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Respiratory Syncytial Virus Vaccines Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Respiratory Syncytial Virus Vaccines Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Respiratory Syncytial Virus Vaccines Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Respiratory Syncytial Virus Vaccines Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Respiratory Syncytial Virus Vaccines Revenue Market Share, 2018-2029
Figure 28. China Respiratory Syncytial Virus Vaccines Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Respiratory Syncytial Virus Vaccines Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Respiratory Syncytial Virus Vaccines Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Respiratory Syncytial Virus Vaccines Revenue, (US$, Mn), 2018-2029
Figure 32. India Respiratory Syncytial Virus Vaccines Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Respiratory Syncytial Virus Vaccines Revenue Market Share, 2018-2029
Figure 34. Brazil Respiratory Syncytial Virus Vaccines Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Respiratory Syncytial Virus Vaccines Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Respiratory Syncytial Virus Vaccines Revenue Market Share, 2018-2029
Figure 37. Turkey Respiratory Syncytial Virus Vaccines Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Respiratory Syncytial Virus Vaccines Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Respiratory Syncytial Virus Vaccines Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Respiratory Syncytial Virus Vaccines Revenue, (US$, Mn), 2018-2029
Figure 41. Pfizer Inc.Pfizer Inc. Respiratory Syncytial Virus Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Sanofi Respiratory Syncytial Virus Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Merck Sharp & Dohme Respiratory Syncytial Virus Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. GlaxoSmithKline Respiratory Syncytial Virus Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. SOBI Respiratory Syncytial Virus Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Johnson & Johnson Respiratory Syncytial Virus Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Bavarian Nordic Respiratory Syncytial Virus Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Novavax Respiratory Syncytial Virus Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. AstraZeneca Respiratory Syncytial Virus Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Moderna Respiratory Syncytial Virus Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Codagenix Respiratory Syncytial Virus Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Intravacc Respiratory Syncytial Virus Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Alphavax Respiratory Syncytial Virus Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
